JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
-
ProQR (PRQR) Prices 13.846M Share Common Offering at $6.50/Sh
-
ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares
-
ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares
-
ProQR Therapeutics N.V. (PRQR) PT Raised to 'Street High' $35 at JMP Securities on Stellar Results
-
ProQR Therapeutics N.V. (PRQR) PT Lowered to $23 at JMP Securities, After Company Reports Findings From Interim Analysis In Phase 1/2 Trial Of QR-421a
-
ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
ProQR (PRQR) Prices 9.09M Share Offering at $5.50/Sh
-
ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares
-
ProQR to Present at the JMP Securities Life Sciences Conference
-
ProQR Therapeutics N.V. (PRQR) PT Raised to $20 at JMP Securities
-
ProQR to Participate in a Cystic Fibrosis Panel Discussion during the JMP Securities Life Science Conference
-
ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference
-
ProQR to Present at the JMP Securities Life Science Conference
-
ProQR to Present at the JMP Securities Life Science Conference
-
ProQR to Present at Two Upcoming Investor Conferences in May
-
ProQR to Present at Two Upcoming Investor Conferences in May
-
JMP Securities Starts ProQR Therapeutics N.V. (PRQR) at Market Outperform
-
ProQR Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
ProQR Therapeutics (PRQR) IPO Opens Sharply Higher
-
ProQR Therapeutics (PRQR) Prices 7.5M Common IPO at $13/Share
-
ProQR Announces Pricing of Initial Public Offering

